Reporting recommendations for tumor marker prognostic studies; REMARK [45] was followed throughout the study. The study design is outlined in Supplementary Figure 5.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.